Shulman DeMeo Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Sell
6,161
-88
-1% -$10.3K 0.15% 50
2026
Q1
$752K Buy
+6,249
New +$721K 0.16% 50
2021
Q2
Sell
-11,385
Closed -$838K 113
2021
Q1
$838K Buy
11,385
+844
+8% +$62.3K 0.23% 50
2020
Q4
$823K Buy
10,541
+1,021
+11% +$78.1K 0.23% 46
2020
Q3
$753K Buy
9,520
+384
+4% +$30.1K 0.25% 46
2020
Q2
$674K Sell
9,136
-94
-1% -$7.08K 0.26% 43
2020
Q1
$678K Sell
9,230
-140
-1% -$11K 0.32% 37
2019
Q4
$813K Buy
9,370
+497
+6% +$40.8K 0.28% 40
2019
Q3
$713K Buy
+8,873
New +$711K 0.24% 45

Other funds holding MRK

Shulman DeMeo Asset Management's MRK Position: Q2 2026 in Review

Shulman DeMeo Asset Management reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $10.3K and leaving 6,161 shares worth $792K. The position accounts for 0.15% of the portfolio, ranked #50.

Shulman DeMeo Asset Management first reported a position in MRK in Q3 2019 and has held it in 9 quarters since. The position peaked at $838K in Q1 2021. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Shulman DeMeo Asset Management held 6,161 shares of Merck worth $792K as of Q2 2026.
  • Shulman DeMeo Asset Management sold 88 Merck shares in Q2 2026, an estimated $10.3K.
  • Merck made up 0.15% of Shulman DeMeo Asset Management's portfolio in Q2 2026, its #50 holding.
  • Shulman DeMeo Asset Management first reported a position in Merck in Q3 2019 and has held it in 9 quarters since.
  • Shulman DeMeo Asset Management's Merck position peaked at $838K in Q1 2021.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Shulman DeMeo Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.